Cardiac device infections are associated with a significant mortality risk

Heart Rhythm

Volumn 9, Issue 4, 2012, Pages 494-498

  De Bie, Mihly K ^a   Van Rees, Johannes B ^a   Thijssen, J ^a   Borleffs, C Jan Willem ^a   Trines, Serge A ^a   Cannegieter, Suzanne C ^a   Schalij, Martin J ^a   Van Erven, Lieselot ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac device infection; Cardiac resynchronization therapy; Implantable cardioverter defibrillator; Infection; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC DEVICE INFECTION; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE INFECTION; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROPIONIBACTERIUM ACNES; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS;

BACTERIAL INFECTIONS; CONFIDENCE INTERVALS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART DISEASES; HUMANS; IATROGENIC DISEASE; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; NETHERLANDS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK;

EID: 84859317329     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.10.034     Document Type: Article

References (24)

1. A.J. Moss, W.J. Hall, D.S. Cannom Multicenter Automatic Defibrillator Implantation Trial Investigators Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia N Engl J Med 335 1996 1933 1940 (Pubitemid 26428217)
2. A.J. Moss, W. Zareba, W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883 (Pubitemid 34984635)
3. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
4. W.T. Abraham, W.G. Fisher, A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853 (Pubitemid 34603028)
5. M.R. Bristow, L.A. Saxon, J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
6. J.G. Cleland, J.C. Daubert, E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549 (Pubitemid 40517094)
7. C.H. Cabell, P.A. Heidenreich, V.H. Chu Increasing rates of cardiac device infections among Medicare beneficiaries: 19901999 Am Heart J 147 2004 582 586 (Pubitemid 38900441)
8. A. Voigt, A. Shalaby, S. Saba Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003 J Am Coll Cardiol 48 2006 590 591 (Pubitemid 44093958)
9. A. Voigt, A. Shalaby, S. Saba Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights Pacing Clin Electrophysiol 33 2010 414 419
10. D. Klug, M. Balde, D. Pavin Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study Circulation 116 2007 1349 1355 (Pubitemid 47417560)
11. J.C. Lekkerkerker, N.C. van, S.A. Trines Risk factors and time delay associated with cardiac device infections: Leiden device registry Heart 95 2009 715 720
12. B.L. Wilkoff How to treat and identify device infections Heart Rhythm 4 2007 1467 1470 (Pubitemid 47578533)
13. M.R. Sohail, D.Z. Uslan, A.H. Khan Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections J Am Coll Cardiol 49 2007 1851 1859 (Pubitemid 46661104)
14. T.B. Ferguson Jr, C.L. Ferguson, K. Crites, P. Crimmins-Reda The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations J Thorac Cardiovasc Surg 111 1996 742 751
15. A. Catanchin, C.J. Murdock, E. Athan Pacemaker infections: a 10-year experience Heart Lung Circ 16 2007 434 439 (Pubitemid 350091403)
16. M. Biffi, M. Ziacchi, M. Bertini Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems Europace 10 2008 1288 1295
17. B.A. Schaer, M.T. Koller, C. Sticherling, D. Altmann, L. Joerg, S. Osswald Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity Heart Rhythm 6 2009 1737 1743
18. C.J. Borleffs, J. Thijssen, M.K. de Bie Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications Pacing Clin Electrophysiol 33 2010 1013 1019
19. K.G. Tarakji, E.J. Chan, D.J. Cantillon Cardiac implantable electronic device infections: presentation, management, and patient outcomes Heart Rhythm 7 2010 1043 1047
20. L.M. Baddour, A.E. Epstein, C.C. Erickson Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association Circulation 121 2010 458 477
21. C. Tompkins, A. Cheng, D. Dalal Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation J Am Coll Cardiol 55 2010 2376 2382
22. O. Cano, J. Osca, M.J. Sancho-Tello, J. Olague, J.E. Castro, A. Salvador Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices Europace 13 2011 395 401
23. I.B. Kutinsky, R. Jarandilla, M. Jewett, D.E. Haines Risk of hematoma complications after device implant in the clopidogrel era Circ Arrhythm Electrophysiol 3 2010 312 318
24. L.K. Hansen, M. Brown, D. Johnson, D.F. Palme Ii, C. Love, R. Darouiche In vivo model of human pathogen infection and demonstration of efficacy by an antimicrobial pouch for pacing devices Pacing Clin Electrophysiol 32 2009 898 907